Beyond The Numbers: 4 Analysts Discuss Puma Biotechnology Stock
Ratings for Puma Biotechnology (NASDAQ:PBYI) were provided by 4 analysts in the past three months, showcasing a mix…
Puma Biotechnology Announced Presentation of Findings From Phase II Study Of Alisertib In Endocrine-Resistant Metastatic Breast Cancer ASCO 2024
Puma Biotechnology, Inc. (NASDAQ:PBYI), a biopharmaceutical company, announced the presentation of biomarker findings from a Phase II randomized clinical trial of alisertib alone vs. alisertib + fulvestrant for the
Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute
A Delaware jury ordered AstraZeneca to pay Pfizer $107.5 million, ruling that AstraZeneca's lung cancer drug Tagrisso infringed on Pfizer's patents related to cancer treatment.
Puma Biotechnology Sees Q2 Net Product Revenue $43M-$45M; FY24 Net Product Revenue $183M-$190M
Second Quarter and Full Year 2024 Financial Outlook Second Quarter 2024Full Year 2024Net Product Revenue$43 -45 million$183 - $190 millionRoyalty Revenue$2.5 - $3 million$30 - $33 millionLicense Revenue$0 million$1
12 Health Care Stocks Moving In Wednesday’s Intraday Session
Gainers Cogent Biosciences (NASDAQ:COGT) stock increased by 64.0% to $8.96 during Wednesday’s regular session. The company’s market cap…
Puma Biotechnology Announces Phase II Clinical Trial Design For Alisertib In HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer; Plans To Initiate Trial In H2 2024
Patients will be dosed with alisertib given at either 30 mg, 40 mg or 50 mg twice daily (BID) on days 1-3, 8-10 and 15-17 on a 28-day cycle in combination with the endocrine therapy of the investigator's choice. Patients
Earnings Scheduled For November 2, 2023
Companies Reporting Before The Bell
• AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on revenue of $61.52 million.
Earnings Scheduled For August 3, 2023
Companies Reporting Before The Bell
• Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.
12 Health Care Stocks Moving In Monday’s Pre-Market Session
Gainers PaxMedica (NASDAQ:PXMD) stock increased by 24.3% to $1.0 during Monday’s pre-market session. The market value of their…
Why Nanobiotix Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
Gainers
Lytus Technologies Holdings PTV. Ltd. (NASDAQ: LYT) shares surged 39.3% to $0.6621 in pre-market trading after gaining around 14% on Wednesday.